SFSIG
KERX

San Francisco Sentry Investment Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

San Francisco Sentry Investment Group’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,400
Closed -$33K – 521
2014
Q3 		$33K Hold
2,400
– – 0.02% 350
2014
Q2 		$37K Hold
2,400
– – 0.02% 354
2014
Q1 		$41K Hold
2,400
– – 0.01% 378
2013
Q4 		$31K Hold
2,400
– – 0.01% 387
2013
Q3 		$24K Hold
2,400
– – 0.01% 394
2013
Q2 		$18K Buy
+2,400
New +$18.8K 0.01% 423

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

San Francisco Sentry Investment Group's KERX Position: Q4 2014 in Review

San Francisco Sentry Investment Group sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2014, closing a stake of 2,400 shares — an estimated $33K sold.

San Francisco Sentry Investment Group first reported a position in KERX in Q2 2013 and held it in 6 quarters. The position peaked at $41K in Q1 2014. 147 funds tracked by Wall St. Rank hold KERX as of Q4 2014.

  • San Francisco Sentry Investment Group reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 2,400 Keryx Biopharmaceuticals Inc shares in Q4 2014, an estimated $33K.
  • San Francisco Sentry Investment Group first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 6 quarters.
  • San Francisco Sentry Investment Group's Keryx Biopharmaceuticals Inc position peaked at $41K in Q1 2014.
  • 147 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2014.

Based on San Francisco Sentry Investment Group's 13F filing for Q4 2014, filed 18 Feb 2015.